Verisk CEO sells 3,535 shares after option exercise

Verisk Analytics, Inc. (VRSK) reports that Chief Executive Officer and director Lee Shavel exercised stock options for 3,535 shares of common stock on September 1, 2026 at an exercise price of $104.00 per share under the company’s 2013 Equity Incentive Plan.

Rhea-AI Filing Summary

Verisk Analytics, Inc. (VRSK) reports that Chief Executive Officer and director Lee Shavel exercised stock options for 3,535 shares of common stock on September 1, 2026 at an exercise price of $104.00 per share under the company’s 2013 Equity Incentive Plan. The resulting 3,535 common shares were then sold the same day at a price of $193.43 per share pursuant to a Rule 10b5-1 trading plan. Following the option exercise, 10,604 stock options from this grant remain outstanding.

Insider Trade Summary 10b5-1

Exercise and Sale: 3,535 shares ($316K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Shavel Lee

Role Chief Executive Officer

Sold 3,535 shs ($684K)

Approx. gross sale proceeds $684K

Approx. exercise cost $368K

Approx. pre-tax spread $316K

Type	Security	Shares	Price	Value
Exercise	Stock Option F2	3,535	$0.00	$0.00
Exercise	Common Stock	3,535	$104.00	$368K
Sale	Common Stock F1	3,535	$193.43	$684K

Holdings After Transaction: Stock Option — 10,604 contracts (Direct); Common Stock — 98,490 shares (Direct)

Footnotes (2)

1. F1. These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Shavel on December 11, 2025.
2. F2. Stock Options outstanding under the Issuer's 2013 Equity Incentive Plan.

Key Figures

Options exercised: 3,535 shares Exercise price: $104.00 per share Shares sold: 3,535 shares +4 more

7 metrics

Options exercised 3,535 shares Stock options converted into common stock on September 1, 2026

Exercise price $104.00 per share Exercise price of stock options exercised on September 1, 2026

Shares sold 3,535 shares Common shares sold by CEO on September 1, 2026

Sale price $193.43 per share Price for common stock sale on September 1, 2026

Options remaining 10,604 stock options Stock options outstanding after exercise from this grant

Option grant exercise date April 1, 2019 Original exercise date stated for the stock options exercised

Option expiration date April 1, 2028 Expiration date of the stock options exercised

Key Terms

Rule 10b5-1 plan, Stock Option, 2013 Equity Incentive Plan

3 terms

Rule 10b5-1 plan regulatory

"These shares were sold pursuant to a 10b5-1 plan entered into"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

Stock Option financial

"Stock Options outstanding under the Issuer's 2013 Equity"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

2013 Equity Incentive Plan financial

"Stock Options outstanding under the Issuer's 2013 Equity Incentive Plan"

FAQ

What insider transaction did Verisk Analytics (VRSK) report for CEO Lee Shavel?

Verisk reported that CEO Lee Shavel exercised 3,535 stock options at $104.00 per share and sold the resulting 3,535 common shares at $193.43 per share on September 1, 2026, in a sequence of option exercise and same-day sale.

How many Verisk (VRSK) shares did the CEO sell in this Form 4?

CEO Lee Shavel sold 3,535 shares of Verisk common stock on September 1, 2026, at a price of $193.43 per share, according to the Form 4 disclosure.

Were the Verisk (VRSK) CEO’s share sales under a Rule 10b5-1 plan?

Yes. The filing states that the 3,535 shares of Verisk common stock sold on September 1, 2026 were sold pursuant to a Rule 10b5-1 plan entered into by Lee Shavel on December 11, 2025.

What stock options did the Verisk (VRSK) CEO exercise in this transaction?

Lee Shavel exercised 3,535 stock options with an exercise price of $104.00 per share, originally granted under Verisk’s 2013 Equity Incentive Plan, converting them into an equal number of common shares on September 1, 2026.

How many Verisk (VRSK) stock options remain from this grant after the CEO’s exercise?

After exercising 3,535 options in this reported transaction, 10,604 stock options from this grant remain outstanding for CEO Lee Shavel, as disclosed in the Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 06:32 PM Accepted by SEC EDGAR 09/02/2026 - 06:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shavel Lee

(Last) (First) (Middle)

C/O VERISK ANALYTICS, INC.

545 WASHINGTON BOULEVARD

(Street)

JERSEY CITY NEW JERSEY 07310

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Verisk Analytics, Inc. [ VRSK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		M		3,535	A	$104	102,025	D
Common Stock	09/01/2026		S		3,535(1)	D	$193.43	98,490	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option(2)	$104	09/01/2026		M			3,535	04/01/2019	04/01/2028	Common Stock	3,535	$0	10,604	D

Explanation of Responses:

1. These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Shavel on December 11, 2025.

2. Stock Options outstanding under the Issuer's 2013 Equity Incentive Plan.

	/s/ Kathy Card Beckles, Attorney-in-fact	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)